浙江医药

- 600216

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
浙江医药(600216) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入224,916.45779,414.60587,651.84393,794.29200,793.51
营业收入224,916.45779,414.60587,651.84393,794.29200,793.51
二、营业总成本213,138.46768,166.56560,728.60370,273.95190,244.83
营业成本150,881.44526,987.87390,351.00260,522.69133,021.99
营业税金及附加2,053.197,842.865,353.913,356.681,626.29
销售费用28,869.99104,558.8275,507.4646,886.5127,197.41
管理费用11,511.6344,518.6130,871.8619,844.9310,583.56
财务费用200.69-1,748.84-2,069.12-3,347.101,144.59
研发费用19,621.5286,007.2460,713.4843,010.2416,670.98
资产减值损失----------
公允价值变动收益-696.32-1,009.94-471.46531.561,131.01
投资收益-150.06-350.48-60.31270.55311.84
其中:对联营企业和合营企业的投资收益-84.50-978.23-699.52-425.49-169.56
汇兑收益----------
三、营业利润10,179.7838,015.8325,925.4225,281.6610,530.25
加:营业外收入28.26179.502,446.452,432.6317.00
减:营业外支出103.591,867.461,533.611,422.78310.97
其中:非流动资产处置损失----------
四、利润总额10,104.4536,327.8726,838.2626,291.5110,236.28
减:所得税费用2,168.118,648.468,751.697,591.461,829.06
五、净利润7,936.3327,679.4118,086.5718,700.058,407.22
归属于母公司所有者的净利润10,964.9642,963.9630,133.8627,226.1111,355.18
少数股东损益-3,028.63-15,284.55-12,047.29-8,526.06-2,947.96
六、每股收益
基本每股收益(元/股)0.11000.45000.31000.28000.1200
稀释每股收益(元/股)0.11000.45000.31000.28000.1200
七、其他综合收益-395.061,171.31575.911,396.80125.89
八、综合收益总额7,541.2828,850.7218,662.4820,096.868,533.12
归属于母公司所有者的综合收益总额10,594.2744,068.3230,682.1028,552.1211,476.05
归属于少数股东的综合收益总额-3,052.99-15,217.60-12,019.62-8,455.26-2,942.94
下载全部历史数据到excel中 返回页顶